Drug
FMX101
FMX101 is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 6 completed trials
Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
17%(1 trials)
Phase Distribution
Ph phase_1
4
67%
Ph phase_3
2
33%
Phase Distribution
4
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
4(66.7%)
Phase 3Large-scale testing
2(33.3%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
6 of 6 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(6)
Detailed Status
Completed6
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 14 (66.7%)
Phase 32 (33.3%)
Trials by Status
completed6100%
Recent Activity
0 active trials
Showing 5 of 6
completedphase_3
To Evaluate the Efficacy and Safety of Minocycline Hydrochloride Foam in the Treatment of Moderate-to-severe Acne Vulgaris
NCT04960930
completedphase_3
A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris
NCT03271021
completedphase_1
Dermal Phototoxicity Study
NCT04070742
completedphase_1
Dermal Cumulative Irritant Patch Study
NCT04064125
completedphase_1
Dermal Photo Allergic Skin Reaction
NCT04070755
Clinical Trials (6)
Showing 6 of 6 trials
NCT04960930Phase 3
To Evaluate the Efficacy and Safety of Minocycline Hydrochloride Foam in the Treatment of Moderate-to-severe Acne Vulgaris
NCT03271021Phase 3
A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris
NCT04070742Phase 1
Dermal Phototoxicity Study
NCT04064125Phase 1
Dermal Cumulative Irritant Patch Study
NCT04070755Phase 1
Dermal Photo Allergic Skin Reaction
NCT04052711Phase 1
A Randomized, Controlled Study to Evaluate the Sensitizing Potential of FMX-101 in Healthy Volunteers Using a Repeat Insult Patch Test Design
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6